bronchiolitis obliterans

Onspira Therapeutics' OSP-101 Receives Orphan Drug Designation for Bronchiolitis Obliterans
CP Wire
Tue, 08/14/18 - 12:09 pm
Onspira Therapeutics
OSP-101
bronchiolitis obliterans